Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
نویسندگان
چکیده
منابع مشابه
Post-injection embolia cutis medicamentosa – Nicolau Syndrome: case report and literature review Embolia cutis medicamentosa pós-injeção – Síndrome de Nicolau: relato de caso e revisão de literatura
We report on the case of a 40-year-old male who was admitted to the clinic with a large ulcer on his left buttock, 3 days after an intramuscular benzathine penicillin injection. The patient was diagnosed with Nicolau syndrome, a rare vascular complication in which a lesion develops after intramuscular injection. Symptoms are intense pain at the injection site, erythema, and livedoid dermatitis,...
متن کاملEmbolia cutis medicamentosa: an unusual adverse reaction to terlipressin
Terlipressin is a synthetic long-acting analog of vasopressin widely used to control variceal bleeding by lowering portal venous pressure. We report an unusual adverse reaction to terlipressin in a 78-year-old patient with esophageal variceal bleeding who developed skin necrosis soon after treatment initiation. Skin biopsy revealed embolia cutis medicamentosa.
متن کامل[Potomania and osmotic imbalance: permanent cortical visual impairment due to extrapontine myelinolysis].
1. Koller S, Kränke B. Nicolau syndrome following subcutaneous glatiramer-acetate injection. J Am Acad Dermatol. 2011;64:16—7. 2. Kim KK. Nicolau syndrome in patient following diclofenac administration: a case report. Ann Dermatol. 2011;23: 501—3. 3. Gaudez C, Regnier S, Aractingi S, Heinzlef O. Livedolike dermatitis (Nicolau’s syndrome) after injection of Copolymer-1 (Glatiramer acetate). Rev ...
متن کاملRecurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection—a case report
BACKGROUND Glatiramer acetate is worldwide used as first line treatment in relapsing remitting multiple sclerosis. Local skin reactions associated with glatiramer acetate are common, however, only isolated cases of severe local injection site reactions known as Nicolau Syndrome have been reported so far. CASE PRESENTATION We describe the case of a recurrent Nicolau Syndrome occurred during lo...
متن کاملTwo decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
Glatiramer acetate, a synthetic amino acid polymer analog of myelin basic protein, is one of the first approved drugs for the treatment of relapsing-remitting multiple sclerosis. Several clinical trials have shown consistent and sustained efficacy of glatiramer acetate 20 mg subcutaneously daily in reducing relapses and new demyelinating lesions on magnetic resonance imaging in patients with re...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Dermatology
سال: 2021
ISSN: 1662-6567
DOI: 10.1159/000510017